Trastuzumab Rezetecan: clinical trials recruiting now

Phase breakdown

Conditions being studied

Recruiting trials involving Trastuzumab Rezetecan

• Real-world Study of Pyrotinib-containing Regimens of Advanced HER2-positive Breast Cancer
  NCT07600164 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• The Efficacy and Safety of Trastuzumab Rezetecan (SHR-A1811) in HER2-Low Unresectable/Metastatic Breast Cancer Patients With Visceral Crisis
  NCT07203729 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: Female · 1 location
• Trastuzumab Rezetecan Combined With Radiotherapy Versus Trastuzumab Rezetecan in the Treatment of HER2-positive Advanced Breast Cancer With Brain Metastases
  NCT07100600 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Female · 1 location
• Trastuzumab Rezetecan in Advanced Solid Tumors Refractory to Standard Therapies
  NCT07309770 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location

Common questions

How many recruiting trials involve Trastuzumab Rezetecan?

4 recruiting trials across 10 conditions.

Is this list of trials complete?

No. For the full record, search ClinicalTrials.gov.